Genetic polymorphisms in IL-10 and IL-12b allele promoter regions in Chinese patients of Han nationality with HBV infection

World Chinese Journal of Digestology

Volumn 11, Issue 8, 2003, Pages 1139-1143

  Li, Yong Gang ^a   Liu, Ming Xu ^a   Wang, Fu Sheng ^a   Jin, Lei ^a   Hong, Wei Guo ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12B; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BLOOD SAMPLING; CHINESE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DNA PURIFICATION; DNA SEQUENCE; ETHNIC GROUP; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; PEDIGREE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PROMOTER REGION; RELATIVE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEQUENCE ANALYSIS;

EID: 0042430592     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: 10.11569/wcjd.v11.i8.1139     Document Type: Article

References (32)

1. Tambur AR, Ortegel JW, Ben-Ari Z, Shabtai E, Klein T, Michowiz R, Tur-Kaspa R, Mor E. Role of cytokine gene polymorphism in hepatitis C recurrence and allograft rejection among liver transplant recipients. Transplantation 2001;71:1475-1480
2. Yu LC, Gu CH. Mutation of hepatitis B virus and its association with liver diseases. Shijie Huaren Xiaohua Zazhi 1999;7: 978-979
3. Wang PZ, Zhang ZW, Zhou YX, Bai XF. Quantitative PCR detection of HBV DNA in patients with chronic hepatitis B and its significance. Shijie Huaren Xiaohua Zazhi 2000;8:755-758
4. Huang QM, Liu HY, Yao ZG, Li YQ, Hong Y. Detection of serum IL-10 and IFN-rin patients with hepatitis B and their significances. Zhongguo Zhongxiyi Jiehe Ganbing Zazhi 2000;10:15-17
5. Du DW, Zhou YX, Feng ZH, Yao ZQ, Li GY. Immune responses to interleukin 12 and hepatitis B gene vaccine in H2 d mice. Shijie Huaren Xiaohua Zazhi 2000;8:128-130
6. Li WB, Yao ZQ, Zhou YX, Feng ZH. Studies on immunization with HBV gene vaccine plus HBsAg protein in mice. Shijie Huaren Xiaohua Zazhi 1999;7:188-190
7. Fan XG, Liu EH, Li CH, Wang ZC, Luo LX, Tan DM, Hu GL. Detection of interleukin in hepatitis C infections. Zhonghua Shiyan He Linchuang Bingduxue Zazhi 2000;14:145-148
8. Gibson AW, Edberg JC, Wu J, Westendorp RGJ, Huizinga TWJ, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 procuction and enhance the risk of systemic lupus erythematosus. J Immunol 2001;166: 3915-3922
9. Wood NA, Keen LJ, Tilley LA, Bidwell JL. Determination of cytokine regulatory haplotypes by induced heteroduplex analysis of DNA. J Immunl Methods 2001;249:191-198
10. Yee LJ, Tang J, Gibson AW, Kimberly R, Van Leeuwen DJ, Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained respose in antiviral therapy for chronic hepatitis Cinfection. Hepatology 2001;33:708-712
11. Wang FS, Jiang JD, Jin L, Liu MX. Comparison of efficient identification of the HIV-1 associated CCR5 gene polymorphism in genomic DNA purified by differnet extraction means from Chinese idividuals. J Chin AIDS/STD Prev Cont 2000;6:5-8
12. Cacciola I, Cerenzia G, Pollicino T, Squadrito G, Castellaneta S, Zanetti AR, Mieli-Vergani G, Raimondo G. Genomic heterogeneity of hepatitis B virus (HBV) and outcome of perinatal HBV infection. J Hepatol 2002;36:426-432
13. Starkel P, Horsmans Y, Geubel A, Ciccarelli O, Goubau P, Rahier J, Lerut J. Favorable outcome of orthotopic liver transplantation in a patient with subacute liver failure due to the emergence of a hepatitis B YMDD escape mutant virus. J Hepatol 2001;35:679-681
14. Chan HL, Tsang SW, Liew CT, Tse CH, Wong ML, Ching JY, Leung NW, Tam JS, Sung JJ. Viral genotype and hepatitis B virus DNA levels are correlated with histological liver damage in HBeAg-negative chronic hepatitis B virus infection.Am J Gastroenterol 2002;97:406-412
15. Zheng B, Woo PC, Ng M, Tsoi H, Wong L, Yuen K. A crucial role of macrophages in the immune to oral DNA vaccination against B virus in a murine model. Vaccine 2002;20:140-147
16. Luisa B, Alfredo A. Patter of hepatocellular carcinoma development in hepatitis B virus related cirrhosis. Antiviral Research 2001;52:199-207
17. Meir S, Orr B, Gilad D, Israel BD, Yosef S. Hepatitis B virus Px interacs with HBXAP, a PHD finger protein to coactivate transcription. The J Biol Chem 2002;277:9982-9988
18. Tai PC, Suk FM, Gerlich WH, Neurath AR, Shih C. Hypermodification and immune escape of an internally deleted middle-envelope(M) protain of frequent and predominant hepatitis B variants. Virology 2002;292:44-58
19. Levy M, Safadi R, Zylber-Katz E, Granit L, Caraco Y. Impairment of the metabolism of dipyrone in asymptomatec carriers of the hepatitis-B virus does not occur in raped acetylators. Eur J Clin Pharmacol 2001;57:461-465
20. Chen M, Sallberg M, Thung SN, Hughes J, Jones J, Milich DR. Modeling the T-helper cell response in acute and chronic hepatitis B virus infection using T-cell receptor transgenic mice. Antiviral research 2001;52:99-111
21. Martin RB, Stephan G, Maura D, Hans W, Jorg P. Structural and functional heterogeneity of naturally occurring hepatitis B virus variants. Antiviral Redearch 2001;52:125-138
22. Hu YP, Hu WJ, Zheng WC, Li JX, Dai DS, Wang XM, Zhang SZ, Yu HY, Sun W, Hao GR. Establishment of transgenic mouse harboring hepatitis B virus (adr subtype) genomes. World J Gastroenterol 2001;7:111-114
23. Brunetto MR, Oliveri F, Coco B, Leandro G, Colombatto P, Gorin JM, Bonino F. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J Hepatol 2002;36:263-270
24. Andreas R, Michael B, Tilman H, Hans W. Antiviral activity of interferon-α agaist hepatits B virus can be studied in non-heptic cells and is independent of MxA. The J Biol Chem 2002; 277:7645-7647
25. Zollner B, Schafer P, Feucht HH, Schroter M, Petersen J, Laufs R. Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy. J Med Virol 2001;65:659-663
26. Pieter H, Robert A, Hubert GM, Pieter EZ, Solko WS. Acute exacerbation of chronic hepatitis Bvirus infection after withdrawal of lanivudine therapy. Hepatology 2000;32:635-639
27. Joseph T, Linda E-S, Georgia D, Kristy E, Hui Z. Reduced antigenicity of the hepatitis Bvirus HbsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 2002;293:305-313
28. Jody LB, Leon G, Stephen L, Don G. Activation of a nonclassical NKTcell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002;16:583-594
29. Weiss P. Safe vaccination against hepatitis B virus and discontinuation of hepatitis B immune globulin treatment in a liver transplanted patient. Transpl Proceed 2000;32:712-713
30. Christopher L, Wills-Karp KM. Complement and IL-12:yin and yang. Microbes Infection 2001;3:109-119
31. Kalinski P, Vieira PL, Schuiternaker JH, de Jong EC, Kapsenberh ML. Prostaglandin E (2)is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood 2001;97:3466-3469
32. Cappiello MG, Sutterwala FS, Trinchieri G, Mosser DM, Ma X. Suppression of IL-12 transcrption in macrphages following Fc recptor ligation. Immunology 2001;4498-4506